Market Cap
$219.5K
RC
RCKTW
ROCKET PHARMACEUTICALS, INC.
—
Market cap$219.5K
High Impact Filing (8/10) Biotech & Drug Discovery
Snapshot
The big-picture read on RCKTW right now — valuation, ownership and activity at a glance.
Cap Size
Nano Cap
Inst. Holders
6 funds
Inst. Value
$4.9K
Inst. Activity
0 buys / 1 sells
SEC Reports
4
Price chart 30d -32.5%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 3, 2026 listing_status
May 13, 2026 SEC Delisted: RCKTW — removed from the Nasdaq symbol directory
Rocket Pharmaceuticals, Inc. - Warrant
Gaurav Shah, an officer and director of Rocket Pharmaceuticals, filed a Form 144 notice of intent to sell 2,728 shares o
144 — Impact 2/10
Rocket Pharmaceuticals reported Q1 2026 net loss of -$47.6M (-$0.42/share), improving from -$61.3M (-$0.56) a year ago.
8-K — Impact 6/10
Officer Sarbani Chaudhuri intends to sell 17,650 shares of RCKTW common stock (approx. $67,740) to cover tax obligations
144 — Impact 3/10
Dec 31, 2025 Inst.
Walleye Capital LLC — TRIM
284,345 shares ($6.9K)
Dec 31, 2024 Inst.
Walleye Trading LLC — DOUBLED
83,991 shares ($2.9K)
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
4 SEC filing reports analyzed · 1 bullish, 0 bearish, 1 mixed, 2 neutral · avg impact 4.8/10.
NEUTRAL1442/10
Gaurav Shah, an officer and director of Rocket Pharmaceuticals, filed a Form 144 notice of intent to
May 13, 2026
MIXED8-K6/10
Rocket Pharmaceuticals reported Q1 2026 net loss of -$47.6M (-$0.42/share), improving from -$61.3M (
May 7, 2026
NEUTRAL1443/10
Officer Sarbani Chaudhuri intends to sell 17,650 shares of RCKTW common stock (approx. $67,740) to c
May 7, 2026
BULLISH8-K8/10
Rocket Pharmaceuticals announced the sale of its Rare Pediatric Disease Priority Review Voucher for
Apr 28, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Sep 3, 2026
listing_status
Delisted: RCKTW — removed from the Nasdaq symbol directory
Rocket Pharmaceuticals, Inc. - Warrant
Sep 3, 2026
trading_halt
Halt Resumed: RCKTW — trading resumed after D (Security Deletion)
Halted 2026-09-02T19:00:00.000Z | Resumed 2026-09-03T04:00:01.000Z
Sep 2, 2026
trading_halt
Trading Halt: RCKTW — T12 (Additional Information Requested)
Rocket Pharmaceuticals, Inc. | Market: NASDAQ | Code: T12 — Additional Information Requested
Sep 2, 2026
trading_halt
Trading Halt: RCKTW — D (Security Deletion)
Rocket Pharmaceuticals, Inc. | Market: NASDAQ | Code: D — Security Deletion
Sep 2, 2026
short_volume
Short Volume: RCKTW — 78.7% short (0.5M / 0.7M)
Short: 546,690 | Exempt: 448,903 | TRF Vol: 694,896 | Short Ratio: 78.7% | Off-exchange volume (dark pool + OTC)
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00–$0.00 | — | — | — | $0.0B | — |
| Next Q | $0.00 | $0.00–$0.00 | — | — | — | $0.0B | — |
| Current FY | $0.00 | $0.00–$0.00 | — | — | — | $0.0B | — |
| Next FY | $0.00 | $0.00–$0.00 | — | — | — | $0.0B | — |
Institutional ownership
Which big funds own RCKTW (from quarterly 13F filings) and who is adding or trimming.
6 institutional holders with $4.9K total value (1,020,644 shares) as of 2026-Q2. Top holders: Clear, CITADEL, Walleye.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| Clear Street Group Inc. | 99 | $0.00 | 0.0% | — |
| CITADEL ADVISORS LLC | 310,370 | $1.9K | 39.3% | — |
| Walleye Capital LLC | 284,345 | $1.4K | 27.9% | TRIM -52.1% |
| RTW INVESTMENTS, LP | 350,000 | $1.2K | 24.3% | — |
| LMR Partners LLP | 75,731 | $364.00 | 7.4% | — |
| TORONTO DOMINION BANK | 99 | $49.00 | 1.0% | — |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| Walleye Capital LLC | TRIM | 593,631 | 284,345 | -52.1% | $6.9K |
| Walleye Trading LLC | DOUBLED | 34,829 | 83,991 | +141.2% | $2.9K |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for RCKTW.
Shares short
55,395
Settlement Aug 31, 2026
Change vs prior
+11.8%
Semi-monthly cycle
Days to cover
1.0
At avg daily volume
Of shares outstanding
≈0.1%
Estimate — not % of float
| Halted | Code | Reason | Status |
|---|---|---|---|
| Sep 2, 2026 | T12 | Info Requested | Not resumed |
| Sep 2, 2026 | D | Deletion | Resumed |
All RCKTW filing & press-release reports (4)
- 144 reportMay 13, 2026
- 8-K reportMay 7, 2026
- 144 reportMay 7, 2026
- 8-K reportApr 28, 2026